42.18 USD (+25.4%)
11 analysts
Trading 2120.30 €Open account ↗
Lightyear0.90 €Open account ↗
N260.90 €Open account ↗
XTB1.00 €★ featured · affiliateOpen account ↗Trading 2120.30 €Open account ↗Lightyear0.90 €Open account ↗XTB1.00 €★ featured · affiliateOpen account ↗200.00 € order · cheapest cheapest available in your country iCompare all 22 brokers →What does it do?
Genpact is a global business process transformation and technology services company that helps large corporations digitalize and optimize their operations through data, AI, and automation solutions.
Key points
from its scores- ✓Attractive valuation8.4
- ✓Favourable backdrop8.0
- ✓Very solid balance sheet7.0
- ✕Poor share-price trend4.9
- !Modest dividend5.9
AI analysis
bottom line, main risk, context and newsValuation is attractive and fundamentals are solid, although moderate growth and negative momentum (-9.29%) limit short-term upside potential.
Genpact shows solid financial health (ND/EBITDA of 1.02, operating margin of 15.02%) and outstanding quality (ROE of 22.45%, ROIC of 19.67%), with an attractive valuation (P/E of 10.01, FCF yield of 8.52%) not backed by accelerated growth (revenue +7.10%), suggesting a value opportunity with stable fundamentals.
The main risk is the slowdown in revenue growth (7.10%) in a highly competitive IT services environment, which could compress margins and limit re-rating despite the cheap valuation.
Context and risks
Domiciled in Bermuda with moderate governance risk, although operations and revenue are globally diversified. There are no recent news or specific regulatory or geopolitical exposures beyond standard jurisdictional risk.
Is Genpact stock cheap or expensive?
at the analysis dateOn P/E and EV / EBITDA, it trades 66% below the Technology median on average.
| Multiple | Company | Sector | Difference |
|---|---|---|---|
| P/E | 10.0 | 31.3 | −68% |
| EV / EBITDA | 7.5 | 20.4 | −63% |
| Price / book | 2.2 | 6.3 | −66% |
| Price / sales | 1.1 | 5.3 | −80% |
Sector: median of the 283 Technology companies analysed. In bold, the multiples used for the comparison.
Valuation score: 8.4 out of 10 (median for Technology: 5.3).
Average analyst target: 42.18 USD, +25.4% versus the price.
A discount may reflect more risk or slower growth than its sector: Financial health 7.0 (sector 6.9), Growth 6.5 (sector 7.5).
Classic formulas with standard assumptions (10.0% growth, 8-9% discount rate). Indicative only: they change a lot with the assumptions and are not a recommendation.
Work out its fair value yourself →How much would you have made investing every month? →
Comparing it with its sector does not say whether it is a good buy: this is not investment advice.
Score by category
0 to 10 · hover overtap each one to see what it measuresKey metrics
at the analysis date · compared with the Technology medianValuation
- P/E
- 10.0
- Forward P/E
- 7.5
- EV / EBITDA
- 7.5
- Price / book
- 2.2
- Price / sales
- 1.1
- PEG
- 1.16
- Market cap
- 5.6B USD
- Enterprise value
- 6.5B USD
Profitability
- ROE
- 22.4%
- ROA
- 9.2%
- ROIC (approx.)
- 19.7%
- Gross margin
- 36.5%
- Operating margin
- 15.0%
- Net margin
- 11.1%
- Free cash flow
- 479.4M USD
- FCF yield
- 8.5%
- Cash conversion
- 55%
Solvency
- Total debt
- 1.4B USD
- Net debt
- 893.9M USD
- Cash
- 520.7M USD
- EBITDA
- 879.0M USD
- Net debt / EBITDA
- 1.02
- Debt / equity
- 54.31
- Current ratio
- 2.00
- Quick ratio
- 1.77
Growth
- Revenue growth
- +7.1%
- Earnings growth
- +14.7%
- EPS (TTM)
- 3.36 USD
- EPS (forward)
- 4.51 USD
Dividend
- Dividend yield
- 2.2%
- Payout
- 21.3%
Risk and market
- Beta
- 0.58
- Analyst consensus
- Buy (11)
- Target price
- 42.18 USD
- 52-week range
- 26.85 – 48.64
Recent news
All G news →Compare it with its sector
All 283 in Technology →Frequently asked questions about Genpact
Is Genpact stock cheap or expensive?
On P/E and EV / EBITDA, it trades 66% below the Technology median on average. Valuation score: 8.4 out of 10 (median for Technology: 5.3). Average analyst target: 42.18 USD, +25.4% versus the price. This is not investment advice.
What score does Genpact get on MeridIAn Screener?
It scores 7.2 out of 10, rank 134 of 2,130 (better than 93% of the companies analysed). Its strongest category is Valuation (8.4) and its weakest, Momentum (4.9). Analysis of 08/10/2026.
What is Genpact's P/E ratio?
Its P/E is 10.0: the share price equals 10.0 times earnings per share over the last 12 months. The Technology median is 31.3. Based on the earnings analysts expect, the forward P/E is 7.5.
How much is Genpact worth on the stock market?
Its market capitalisation is 5.6B USD and its enterprise value, debt included, is 6.5B USD.
How much debt does Genpact have?
Its net debt (debt minus cash) is 893.9M USD. That is 1.02 times its EBITDA; the Technology median is 0.20.
Does Genpact pay a dividend?
Yes: its dividend yield is 2.23% and it pays out 21% of its earnings.
How has Genpact stock performed over the last year?
It has fallen 13.1% over the last year, excluding dividends. Over the last 52 weeks it has traded between 26.85 and 48.64 USD. Past performance does not guarantee future results.
What do analysts think of Genpact?
11 analysts cover it; their average recommendation is “Buy” and their average target is 42.18 USD (+25.4% versus the price). It is an estimate, not market data.